Almost every year, the biggest story in the world of infectious diseases is likely to be the one most unanticipated by experts. This is true with the outbreak of Ebola, Zika, or SARS in recent years. But a persistent annual issue is antibiotics resistance.
![]() |
| Image source: evidencenetwork.ca |
While influenza and opioids are among the top headline-makers of 2017 and early this year, it’s the progressive occurrence of antibiotic infections with multi-resistance that’s challenging many doctors globally. Finding effective treatment is a global imperative, exemplified in the rise of multi-drug resistant gonorrhea just last year. Research of two-thirds of cases in as many as 77 countries showed a lowered sensitivity of gonorrhea to the antibiotic spectrum. In short, it’s getting much harder to cure the disease.
The U.S. FDA is helping with online awareness campaigns designed to assist doctors in managing their prescriptions of antibiotics. But compounding the problem is the issue of supply, with national shortages of antibiotics rampant in many countries. Aside from the antibiotics themselves, the saline required to infuse them is growing scarce.
![]() |
| Image source: popsci.com |
If antibiotics resistance is not given more intent attention, and a more collective effort among physicians worldwide, it may lead to more serious infections in the near future. Doctors can start addressing the problem by considering older, less expensive treatments before prescribing more powerful medications that fast-track resistance.
Captain Martin Lloyd Sanders, Ph.D., obtained his degree in zoology at the University of California and his doctorate from the Department of Immunology and Infectious Diseases at the Johns Hopkins University School of Hygiene and Public Health. Visit this Facebook page for similar updates.



